iCAD’s two new MRI products — SpectraLook, an iCAD’s image analysis solution for breast and prostate MRI studies, and CADvue, an image review and analysis software for breast MR — to be unveiled at the 7th Annual Symposium on Advances in Breast MRI in Las Vegas, from October 16-18, 2008.
SpectraLook, iCAD’s breast MR analysis solution, provides more diagnostic information by creating colorized images based on signal changes defined by tumor physiology. iCAD’s All Time Point (ATP) analysis is based on an advanced pharmacokinetic model that calculates numerical values of key physiological parameters, allowing the user to detect the different biological processes taking place in malignant versus benign tumors. These key physiological markers can aid in the analysis of large MR datasets.
CADvue image review and analysis software provides maximum functionality facilitating the analysis of ATP colorized images and quantitative data. CADvue allows the user to create standard and customized reports that enable the user to communicate time-sensitive breast MR study results to referring physicians. The reports provide detailed and comprehensive information that is critical to the identification and analysis of abnormalities. 3D colorized images within the report assist clinicians to effectively communicate options to their patients.
July 24, 2024 
